ArticleBMC microbiology2026
Associations of indoor bacterial, metabolomic, and other chemical exposures with allergic rhinitis in school-aged children.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe indoor environment has been implicated as a critical factor in the development of allergic diseases. However, the interplay among indoor microbiota, metabolites, and other environmental chemicals in relation to childhood allergic rhinitis (AR) remains underexplored, particularly in subtropical regions. This study investigates the joint associations of multi-omics profiles in classroom dust with AR prevalence among school-aged children in southern China.
methodsThis cross-sectional study was conducted in 2023 across 45 middle schools in Guangzhou, China, encompassing 3,944 students. Classroom dust was analyzed using 16S rRNA gene sequencing for bacterial community profiling and untargeted UHPLC-MS/MS for small-molecule compound profiling (including metabolites and environmental chemicals). Classrooms were stratified into high- and low-AR prevalence groups based on the median AR prevalence. Multivariate statistics, machine learning (random forest with SHAP), and interaction analysis were employed to compare bacterial communities and compound profiles between the two groups and to examine the joint effects of bacterial-compound pairs on AR prevalence.
resultsSignificant differences in bacterial β-diversity were observed between high- and low-AR prevalence classrooms (PERMANOVA, p < 0.05). At the genus level, low-AR prevalence classrooms were enriched with environmental bacteria including Pseudorhodoferax, Cupriavidus, Enterobacter, and Marmoricola, whereas high-AR prevalence classrooms showed higher relative abundances of Sutterella, Tannerella, Bifidobacterium, Fusobacterium, Bacteroides, and Lawsonella. A total of 395 small-molecule compounds were differentially abundant between groups (variable importance in projection [VIP] > 1, p < 0.05), of which 239 were elevated in high-prevalence classrooms and 156 in low-prevalence classrooms. Interaction analysis revealed a significant signal intensity-dependent interaction between Tannerella and the oxidized ceramide Cer(d17:1/6 keto-PGF1alpha) (FDR = 0.002): Tannerella was positively associated with AR prevalence at low ceramide levels but negatively associated at high levels.
conclusionsClassroom bacterial community composition and small-molecule compound profiles are associated with AR prevalence among school-aged children in subtropical South China. Specific environmental compounds can substantially modify the direction of the association between bacteria and AR, highlighting the need to move beyond traditional diversity-based approaches and integrate multi-omics data to identify modifiable environmental exposure risks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.